Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

74.20p
   
  • Change Today:
      0.50p
  • 52 Week High: 80.40
  • 52 Week Low: 60.00
  • Currency: UK Pounds
  • Shares Issued: 526.14m
  • Volume: 226,937
  • Market Cap: 390.40m
  • RiskGrade: 121
  • Beta: 0.06

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 74.20p per share. In the last year Alliance Pharma's share price has ranged from 60.00p to 80.40p and brokers are currently rating this stock as 'buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 2.0% 2.2%
Div Cover 3.1 3.1
Op Mrgn 20.0% 22.9%
ROCE 60.6%  
Latest F'cast
P/E 16.2 14.7
PEG n/a 1.4
Pr/Revenue 3.3 2.7
Pr/Book 1.5  
Latest F'cast
Revenue 16.3% 21.5%
PBT -19.4% 44.3%
EPS -14.8% 10.2%
DPS 10.0% 9.1%

Alliance Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 43.54 10.16 3.36p 10.9 n/a -12% 1.00p 2.7%
31-Dec-15 48.34 15.18 3.52p 12.2 2.4 +5% 1.10p 2.6%
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 143.63 32.90 5.00p 14.7 1.4 +10% 1.60p 2.2%
31-Dec-20 152.20 36.00 5.48p 13.5 1.4 +9% 1.76p 2.4%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Total Voting Rights 05-Nov-2019 15:51 RNS
Director's Dealing 09-Oct-2019 11:14 RNS
Total Voting Rights 03-Oct-2019 07:00 RNS

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 74.20p
Change Today 0.50p
% Change 0.68 %
52 Week High 80.40
52 Week Low 60.00
Volume 226,937
Shares Issued 526.14m
Market Cap 390.40m
Beta 0.06
RiskGrade 121

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
0.17% below the market average0.17% below the market average0.17% below the market average0.17% below the market average0.17% below the market average
96.55% above the sector average96.55% above the sector average96.55% above the sector average96.55% above the sector average96.55% above the sector average
Price Trend
45.80% above the market average45.80% above the market average45.80% above the market average45.80% above the market average45.80% above the market average
45.76% above the sector average45.76% above the sector average45.76% above the sector average45.76% above the sector average45.76% above the sector average
Income
42.18% below the market average42.18% below the market average42.18% below the market average42.18% below the market average42.18% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Growth
5.81% below the market average5.81% below the market average5.81% below the market average5.81% below the market average5.81% below the market average
2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Dec-19 13-Jun-19
Paid 10-Jan-20 11-Jul-19
Amount 0.54p 0.98p

Trades for 15-Nov-2019

Time Volume / Share Price
16:14 7,386 @ 74.02p
16:06 156 @ 74.00p
15:58 4,000 @ 74.27p
15:52 133 @ 74.40p
15:46 1,369 @ 74.20p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page